Osteoarthritis (OA) is a degenerative disease characterized by progressive destruction of the extracellular matrix (ECM) of articular cartilage, synovial inflammation, subchondral bone sclerosis and osteophyte formation. OA is most common in the knee; the hip and fingers also are frequently affected. In general, weight-bearing joints are the most severely affected. OA is one of the most common chronic diseases in the elderly. There are no approved disease-modifying drugs for OA; pain and inflammation are managed using analgesics, corticosteroids and NSAIDs.
Pathophysiology
Structural damage, even minor injury, to cartilage manifests as an inability to heal. Aging also leads to changes in ECM composition and alters chondrocyte activity. Compared with normal aging chondrocytes, those isolated from OA cartilage show different patterns of protein expression (Table). After cartilage in OA-affected joints begins to degenerate, ECM degradation products are released into the synovial fluid, which in turn, stimulates the release of pro-inflammatory cytokines. These molecules increase the expression of various catabolic enzymes, including matrix metalloproteinases (MMPs).
Table. Changes in cartilage properties with aging versus osteoarthritis
Property
Aging
Osteoarthritis
Water content
Decreased
Increased
Collagen
Relatively unchanged (some increased in type VI)
Relative concentration increased Content decreased in severe cases
Matrix becomes disordered
Proteoglycan concentration
Proteoglycan synthesis
Unchanged
Proteoglycan degradation
Total chondroitin sulfate concentration
Chondroitin-4-sulfate concentration
Keratin sulfate concentration
Chondrocyte size
Chondrocyte number
Modulus of elasticity
Incidence and Related Conditions
Differential Diagnosis
Thumb CMC Osteoarthritis:
In a recent Cochrane Systematic review,1 11 randomized/quasi-randomized trials of surgery for thumb OA were included (N=670 patients), and 7 surgical procedures were identified:
DIP Osteoarthritis of the Finger:
Wrist osteoarthritis such as sccapholunated advanced collapse (SLAC) wrist:
As reported in the Cochrane review, the AE rate was 10% after trapeziectomy and 19% after trapeziectomy with LRTI, corresponding to a ris As reported in the Cochrane review, trapeziectomy with LRTI may not confer additional benefits or result in more adverse events (AEs) versus trapeziectomy.
- On a visual analog scale (VAS) from 0 (no pain) to 100 mm, mean pain was 26 mm for trapeziectomy; trapeziectomy with LRTI reduced pain by 2.8 mm (95% confidence interval [CI] -9.8, 4.2).
- On a scale of 0 (no disability) to 100, physical function was 31.1 after trapeziectomy; trapeziectomy with LRTI resulted a worsening in physical function of 0.2 points (95% CI −5.8, 6.1).k increase of 9% (95% CI 0%, 28%).
Cited
New Articles
Reviews
Classics